Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8640, Japan.
J Biochem. 2010 May;147(5):651-9. doi: 10.1093/jb/mvp207. Epub 2009 Dec 21.
Receptor for advanced glycation endproducts (RAGE) is a cell-surface receptor. The binding of ligands to membrane-bound RAGE (mRAGE) evokes cellular responses involved in various pathological processes. Previously, we identified a novel soluble form, endogenous secretory RAGE (esRAGE) generated by alternative 5' splice site selection in intron 9 that leads to extension of exon 9 (exon 9B). Because esRAGE works as an antagonistic decoy receptor, the elucidation of regulatory mechanism of the alternative splicing is important to understand RAGE-related pathological processes. Here, we identified G-rich cis-elements within exon 9B for regulation of the alternative splicing using a RAGE minigene. Mutagenesis of the G-rich cis-elements caused a drastic increase in the esRAGE/mRAGE ratio in the minigene-transfected cells and in loss of binding of the RNA motif to heterogenous nuclear ribonucleoprotein (hnRNP) H. On the other hand, the artificial introduction of a G-stretch in exon 9B caused a drastic decrease in the esRAGE/mRAGE ratio accompanied by the binding of hnRNP H to the RNA motif. Thus, the G-stretches within exon 9B regulate RAGE alternative splicing via interaction with hnRNP H. The findings should provide a molecular basis for the development of medicines for RAGE-related disorders that could modulate esRAGE/mRAGE ratio.
晚期糖基化终产物受体(RAGE)是一种细胞表面受体。配体与膜结合的 RAGE(mRAGE)的结合引发了涉及各种病理过程的细胞反应。先前,我们通过 9 号内含子中的替代 5'剪接位点选择鉴定了一种新型可溶性形式,即内源性分泌 RAGE(esRAGE),该形式导致 9 号外显子(外显子 9B)的延伸。由于 esRAGE 作为拮抗诱饵受体起作用,因此阐明替代剪接的调节机制对于理解 RAGE 相关的病理过程非常重要。在这里,我们使用 RAGE 基因座鉴定了 9B 号外显子内的富含 G 的顺式元件,用于调节替代剪接。富含 G 的顺式元件的突变导致基因座转染细胞中外显子 9B 的 esRAGE/mRAGE 比值急剧增加,并且 RNA 基序与异质核核糖核蛋白(hnRNP)H 的结合丧失。另一方面,人工引入 9B 号外显子中的 G 延伸导致 esRAGE/mRAGE 比值急剧下降,同时 hnRNP H 与 RNA 基序结合。因此,9B 号外显子内的 G 延伸通过与 hnRNP H 的相互作用调节 RAGE 替代剪接。这些发现应为开发可调节 esRAGE/mRAGE 比值的 RAGE 相关疾病药物提供分子基础。